Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 3/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | DRD1 | P21728 | 1/20 | 0.32 |
| ▸ | FADS1 | O60427 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 2/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18911162 | 0.83 | HTR2C (0.37) | HTR2CTRPA1DRD1FADS1HTR2B | |
| SCHEMBL20124907 | 0.81 | TRPA1 (0.35) | HTR2CTRPA1 | |
| SCHEMBL21134630 | 0.78 | ALDH1A1 (0.36) | HTR2CTRPA1DRD1FADS1HTR2B | |
| SCHEMBL18903869 | 0.78 | CYP1A1 (0.31) | CYP1B1 | |
| SCHEMBL18531147 | 0.73 | CYP2A6 (0.44) | ALDH1A1LMNA | |
| SCHEMBL18911271 | 0.72 | TRPA1 (0.39) | HTR2CTRPA1DRD1FADS1HTR2B | |
| SCHEMBL12985283 | 0.69 | KDM4E (0.43) | HTR2CTRPA1FADS1ALDH1A1 | |
| SCHEMBL19390678 | 0.69 | TRPA1 (0.40) | HTR2CTRPA1DRD1 | |
| SCHEMBL31426140 | 0.68 | L3MBTL1 (0.44) | HTR2CTRPA1DRD1FADS1HTR2A | |
| SCHEMBL9109490 | 0.68 | HTR2C (0.36) | HTR2CTRPA1DRD1FADS1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10340466-B2 | Organic metal compound, organic light-emitting devices employing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2019-07-02 | — | — | US | disclosed |
| US-20170155065-A1 | ORGANIC METAL COMPOUND, ORGANIC LIGHT-EMITTING DEVICES EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2017-06-01 | — | — | US | disclosed |
| EP-3173418-A1 | ORGANIC METAL COMPOUND, ORGANIC LIGHT-EMITTING DEVICES EMPLOYING THE SAME | Industrial Technology Research Institute (TW) | 2017-05-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10340466-B2 | Organic metal compound, organic light-emitting devices employing the same | OR10J3, C1S, C5 | HTR2C 1233/4885TRPA1 57/4885DRD1 45/4885 |
| US-20170155065-A1 | ORGANIC METAL COMPOUND, ORGANIC LIGHT-EMITTING DEVICES EMPLOYING THE SAME | OR10J3, C1S, C5 | HTR2C 1233/4885TRPA1 57/4885DRD1 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.